Harnessing post-translational modifications for a tuberculosis booster vaccine

FHS
June 19, 2024
4:26 pm

Tuberculosis is still one of the deadliest infectious diseases, causing over one million deaths each year worldwide.

Current AI programs do worse at identifying skin lesions in people of color, research shows

Artificial intelligence (AI) programs have recently acquired widespread popularity in dermatology for assessing, diagnosing, and treating skin conditions.

March 7, 2024

Ocular launches ocular implant trial to combat macular degeneration – Pharmaceutical Technology

Ocular Therapeutix has announced the start of its first clinical trial of an intravitreal eye implant, which it hopes will improve patient outcomes. Credit: Shutterstock

October 6, 2023

Evidence Still Lacking for Iron Deficiency Screening, Supplementation in Pregnancy

While prenatal iron supplementation reduces the incidence of iron deficiency and iron deficiency anemia in pregnancy, health outcomes for moms and babies are unclear, according

August 21, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.